Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease

Chaiwong, W; Takheaw, N; Pata, S; Laopajon, W; Duangjit, P; Inchai, J; Pothirat, C; Bumroongkit, C; Deesomchok, A; Theerakittikul, T; Limsukon, A; Tajarernmuang, P; Niyatiwatchanchai, N; Trongtrakul, K; Chuensirikulchai, K; Cheyasawan, P; Liwsrisakun, C; Kasinrerk, W

Liwsrisakun, C (通讯作者),Chiang Mai Univ, Fac Med, Dept Internal Med, Div Pulm Crit Care & Allergy, Chiang Mai, Thailand.;Kasinrerk, W (通讯作者),Chiang Mai Univ, Fac Assoc Med Sci, Dept Med Technol, Div Clin Immunol, Chiang Mai, Thailand.

VACCINE, 2023; 41 (40): 5901

Abstract

Background: Data on humoral and cellular immune responses against SARS-CoV-2 after receiving heterologous CoronaVac/ChAdOx-1 (CoVac/ChAd) vaccination ......

Full Text Link